A drug that is used to treat cutaneous T-cell lymphoma that does not get better, gets worse, or comes back during or after treatment with other drugs. It is also being studied in the treatment of other types of cancer. SAHA is a type of histone deacetylase inhibitor. Also called suberoylanilide hydroxamic acid, vorinostat, and Zolinza.